We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

December 29, 2011

In Re: Actos (Pioglitazone) Products Liability Litigation

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


  1. September 14, 2015

    Takeda Says Most Actos Claimants Want In On $2.4B Deal

    Takeda Pharmaceutical Company Ltd. said Friday that more than 96 percent of claimants have sought a share of the Japanese drugmaker's proposed deal of up to $2.4 billion to resolve claims that it hid the alleged bladder cancer risks of its diabetes drug Actos. 

15 other articles on this case. View all »


To view the parties, register now.